Article

Efficient shRNA-Mediated Inhibition of Gene Expression in Zebrafish

1 Whitehead Institute for Biomedical Research , Cambridge Massachusetts.
Zebrafish (Impact Factor: 1.77). 07/2012; 9(3):97-107. DOI: 10.1089/zeb.2012.0770
Source: PubMed

ABSTRACT Abstract Despite the broad repertoire of loss of function (LOF) tools available for use in the zebrafish, there remains a need for a simple and rapid method that can inhibit expression of genes at later stages. RNAi would fulfill that role, and a previous report (Dong et al. 2009) provided encouraging data. The goal of this study was to further address the ability of expressed shRNAs to inhibit gene expression. This included quantifying RNA knockdown, testing specificity of shRNA effects, and determining whether tissue-specific LOF could be achieved. Using an F0 transgenic approach, this report demonstrates that for two genes, wnt5b and zDisc1, each with described mutant and morphant phenotypes, shRNAs efficiently decrease endogenous RNA levels. Phenotypes elicited by shRNA resemble those of mutants and morphants, and are reversed by expression of cognate RNA, further demonstrating specificity. Tissue-specific expression of zDisc1 shRNAs in F0 transgenics demonstrates that conditional LOF can be readily obtained. These results suggest that shRNA expression presents a viable approach for rapid inhibition of zebrafish gene expression.

Download full-text

Full-text

Available from: Jennifer H Gutzman, Jun 02, 2015
1 Follower
 · 
109 Views
  • Source
    • "Here, artificially constructed miRNAs based on the endogenous miRNA backbone of mir30e are inserted within a transgene and transcribed from a pol II promoter. However , conflicting results in zebrafish indicate that the use of shRNAs may not be applicable for all target genes and its functionality needs to be thoroughly tested on a case-bycase basis (Dong et al. 2009; Kelly and Hurlstone 2011; De Rienzo et al. 2012). Nevertheless, the use of shRNAs seems a promising approach to down-regulate gene expression levels in a controlled and tissue-specific manner in fish model systems (Dong et al. 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The Japanese medaka, Oryzias latipes, is a vertebrate teleost model with a long history of genetic research. A number of unique features and established resources distinguish medaka from other vertebrate model systems. A large number of laboratory strains from different locations are available. Due to a high tolerance to inbreeding, many highly inbred strains have been established, thus providing a rich resource for genetic studies. Furthermore, closely related species native to different habitats in Southeast Asia permit comparative evolutionary studies. The transparency of embryos, larvae, and juveniles allows a detailed in vivo analysis of development. New tools to study diverse aspects of medaka biology are constantly being generated. Thus, medaka has become an important vertebrate model organism to study development, behavior, and physiology. In this review, we provide a comprehensive overview of established genetic and molecular-genetic tools that render medaka fish a full-fledged vertebrate system.
    Genetics 04/2015; 199(4):905-918. DOI:10.1534/genetics.114.173849 · 4.87 Impact Factor
  • Source
    • "The rapid development of organ primordia (within 5 d post-fertilization [dpf]) and onset of adult metamorphosis (within 14 dpf), together with small size, make zebrafish an invaluable resource for forward genetic and chemical screening. Methods for genetic screening include ENU mutagenesis, retrovirus-based insertional mutagenesis, zinc finger nucleases (Amacher 2008), morpholino-based gene knockdown (Nasevicius and Ekker 2000), conditional loss of function by RNAi (De Rienzo et al. 2012), and, most recently, genome editing with the use of the TALEN system (Bedell et al. 2012). There is a high degree of homology between zebrafish and mammals not only in the adaptive immune system, but also in the digestive system. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The animal and bacterial kingdoms have coevolved and coadapted in response to environmental selective pressures over hundreds of millions of years. The meta'omics revolution in both sequencing and its analytic pipelines is fostering an explosion of interest in how the gut microbiome impacts physiology and propensity to disease. Gut microbiome studies are inherently interdisciplinary, drawing on approaches and technical skill sets from the biomedical sciences, ecology, and computational biology. Central to unraveling the complex biology of environment, genetics, and microbiome interaction in human health and disease is a deeper understanding of the symbiosis between animals and bacteria. Experimental model systems, including mice, fish, insects, and the Hawaiian bobtail squid, continue to provide critical insight into how host-microbiota homeostasis is constructed and maintained. Here we consider how model systems are influencing current understanding of host-microbiota interactions and explore recent human microbiome studies.
    Genes & development 04/2013; 27(7):701-718. DOI:10.1101/gad.212522.112 · 12.64 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Deletion or duplication of one copy of the human 16p11.2 interval is tightly associated with impaired brain function, including autism spectrum disorders (ASDs), intellectual disability disorder (IDD) and other phenotypes, indicating the importance of gene dosage in this copy number variant region (CNV). The core of this CNV includes 25 genes; however, the number of genes that contribute to these phenotypes is not known. Furthermore, genes whose functional levels change with deletion or duplication (termed 'dosage sensors'), which can associate the CNV with pathologies, have not been identified in this region. Using the zebrafish as a tool, a set of 16p11.2 homologs was identified, primarily on chromosomes 3 and 12. Use of 11 phenotypic assays, spanning the first 5 days of development, demonstrated that this set of genes is highly active, such that 21 out of the 22 homologs tested showed loss-of-function phenotypes. Most genes in this region were required for nervous system development - impacting brain morphology, eye development, axonal density or organization, and motor response. In general, human genes were able to substitute for the fish homolog, demonstrating orthology and suggesting conserved molecular pathways. In a screen for 16p11.2 genes whose function is sensitive to hemizygosity, the aldolase a (aldoaa) and kinesin family member 22 (kif22) genes were identified as giving clear phenotypes when RNA levels were reduced by ~50%, suggesting that these genes are deletion dosage sensors. This study leads to two major findings. The first is that the 16p11.2 region comprises a highly active set of genes, which could present a large genetic target and might explain why multiple brain function, and other, phenotypes are associated with this interval. The second major finding is that there are (at least) two genes with deletion dosage sensor properties among the 16p11.2 set, and these could link this CNV to brain disorders such as ASD and IDD.
    Disease Models and Mechanisms 05/2012; 5(6). DOI:10.1242/dmm.009944 · 5.54 Impact Factor
Show more